Normal intelligence in children with prenatal exposure to carbamazepine

Area of Science:

• Neuroscience
• Developmental Pediatrics
• Pharmacology

Background:

• Epilepsy affects women of childbearing age.
• Antiepileptic drugs (AEDs) are crucial for seizure control but may pose risks to fetal development.
• Understanding the neurodevelopmental effects of specific AEDs is vital for informed treatment decisions.

Purpose of the Study:

• To evaluate the impact of prenatal exposure to specific antiepileptic drugs, namely carbamazepine and valproate, on the intelligence of children born to mothers with epilepsy.
• To compare intelligence outcomes between children exposed to monotherapy, polytherapy, and unexposed controls.

Main Methods:

• A cohort study involving 182 children exposed prenatally to AEDs and 141 control children.
• Intelligence was assessed using the Wechsler Preschool and Primary Scale of Intelligence-Revised or Wechsler Intelligence Scale for Children-Revised in a blinded manner.
• Maternal AED treatment, seizure history, and drug levels were prospectively collected.

Main Results:

• Children exposed to carbamazepine monotherapy showed no significant difference in verbal or nonverbal IQ compared to controls.
• Significantly lower verbal IQ scores were observed in children exposed prenatally to valproate monotherapy and to polytherapy.
• Maternal serum levels of carbamazepine were within the reference range for monotherapy cases.

Conclusions:

• Carbamazepine monotherapy, within therapeutic ranges, appears safe regarding offspring intelligence.
• Prenatal exposure to valproate and polytherapy AEDs is associated with impaired verbal intelligence in children.
• Further research is needed to confirm the independent effects of valproate due to confounding factors like maternal education and polytherapy.